Market Tracker

11/28 9:34am ET

Theravance Inc (NASDAQ:THRX)

15.19
Real-Time Quote
 -0.06 / -0.39%
Today’s Change
12.78
Today|||52-Week Range
32.88
-47.11%
Year-to-Date

Today’s Trading

Previous close15.25
Today’s openn.a.
Day’s range-- - --
Volume2,055
Average volume (3 months)973,241
Market cap$1.8B
Dividend yield6.56%
Data as of 11/26/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+29.51%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book5.69

Competitors

 Today’s
change
Today’s
% change
AUXLAuxilium Pharmaceuti...0.000.00%
LCILannett Company Inc+0.52+1.05%
CBPOChina Biologic Produ...0.000.00%
MDCOMedicines Co-0.04-0.15%
Data as of 9:33am ET, 11/28/2014

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts